SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-13-033660
Filing Date
2013-02-01
Accepted
2013-02-01 09:02:09
Documents
6
Period of Report
2013-01-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d479049d8k.htm 8-K 23023
2 PLACEMENT AGENCY AGREEMENT d479049dex11.htm EX-1.1 119231
3 FORM OF COMMON STOCK PURCHASE WARRANT d479049dex41.htm EX-4.1 83431
4 OPINION OF COOLEY LLP d479049dex51.htm EX-5.1 9664
5 SUBSCRIPTION AGREEMENT d479049dex101.htm EX-10.1 142996
6 GRAPHIC g479049g29m82.jpg GRAPHIC 5343
  Complete submission text file 0001193125-13-033660.txt   387168
Mailing Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021
Business Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22873 | Film No.: 13564845
SIC: 2835 In Vitro & In Vivo Diagnostic Substances